Douglas A. Dyer
Algemeen Directeur bij Grace 3, Inc.
Actieve functies van Douglas A. Dyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Grace 3, Inc.
 Grace 3, Inc. Financial ConglomeratesFinance Grace 3, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on October 27, 2005 and is headquartered in Red Bank, NJ. | Algemeen Directeur | 23-09-2009 | - |
| Financieel Directeur/CFO | 23-09-2009 | - | |
| President | 23-09-2009 | - |
Loopbaan van Douglas A. Dyer
Eerdere bekende functies van Douglas A. Dyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Directeur/Bestuurslid | 04-07-2011 | 18-10-2011 |
| Financieel Directeur/CFO | 23-09-2009 | 04-07-2011 | |
| Corporate Officer/Principal | 04-07-2011 | 04-07-2011 | |
| President | 23-09-2009 | 18-10-2011 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| President | 2 |
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Grace 3, Inc.
Grace 3, Inc. Financial ConglomeratesFinance Grace 3, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on October 27, 2005 and is headquartered in Red Bank, NJ. | Finance |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
- Beurs
- Insiders
- Douglas A. Dyer
- Ervaring
